§ 13F · FUND PROFILE
Kynam Capital Management, LP.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 39Turnover · — · Q1Filed · May 15, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$109M deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q1 2026
FILED MAY 15, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q1 |
|---|---|---|---|---|---|---|
| 1 | SNDX | SYNDAX PHARMACEUTICALS INC | 8.05M | $188M | 11.6% | ±0% |
| 2 | CLDX | CELLDEX THERAPEUTICS INC NEW | 5.84M | $185M | 11.4% | −2% |
| 3 | PCVX | VAXCYTE INC | 2.92M | $170M | 10.5% | ±0% |
| 4 | COGT | COGENT BIOSCIENCES INC | 4.04M | $155M | 9.6% | −35% |
| 5 | VERA | VERA THERAPEUTICS INC | 3.40M | $137M | 8.4% | −1% |
| 6 | BEAM | BEAM THERAPEUTICS INC | 3.68M | $88M | 5.4% | +9% |
| 7 | CTMX | CYTOMX THERAPEUTICS INC. | 15.01M | $71M | 4.4% | +67% |
| 8 | BCRX | BIOCRYST PHARMACEUTICALS INC | 5.68M | $54M | 3.3% | −39% |
| 9 | TVTX | TRAVERE THERAPEUTICS INC | 1.57M | $47M | 2.9% | +368% |
| 10 | VRDN | VIRIDIAN THERAPEUTICS INC | 2.34M | $46M | 2.8% | +59% |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE KYNAM SIGNAL
AC read
Kynam Capital Management, LP is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q1 2026
Steady book
+0 buys · −0 exits · 0 changed
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed